These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 25033984)

  • 1. Termination of immune activation: an essential component of healthy host immune responses.
    Kane BA; Bryant KJ; McNeil HP; Tedla NT
    J Innate Immun; 2014; 6(6):727-38. PubMed ID: 25033984
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TLR signaling by a bacterial protein containing immunoreceptor tyrosine-based inhibitory motifs.
    Yan D; Wang X; Luo L; Cao X; Ge B
    Nat Immunol; 2012 Nov; 13(11):1063-71. PubMed ID: 23001144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglial activatory (immunoreceptor tyrosine-based activation motif)- and inhibitory (immunoreceptor tyrosine-based inhibition motif)-signaling receptors for recognition of the neuronal glycocalyx.
    Linnartz B; Neumann H
    Glia; 2013 Jan; 61(1):37-46. PubMed ID: 22615186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory ITAMs: a matter of life and death.
    Pinheiro da Silva F; Aloulou M; Benhamou M; Monteiro RC
    Trends Immunol; 2008 Aug; 29(8):366-73. PubMed ID: 18602341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoreceptor tyrosine-based inhibitory motif (ITIM)-mediated inhibitory signaling is regulated by sequential phosphorylation mediated by distinct nonreceptor tyrosine kinases: a case study involving PECAM-1.
    Tourdot BE; Brenner MK; Keough KC; Holyst T; Newman PJ; Newman DK
    Biochemistry; 2013 Apr; 52(15):2597-608. PubMed ID: 23418871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ITIM receptors: more than just inhibitors of platelet activation.
    Coxon CH; Geer MJ; Senis YA
    Blood; 2017 Jun; 129(26):3407-3418. PubMed ID: 28465343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. You say ITAM and I say ITIM, let's call the whole thing off: the ambiguity of immunoreceptor signalling.
    Barrow AD; Trowsdale J
    Eur J Immunol; 2006 Jul; 36(7):1646-53. PubMed ID: 16783855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Counteracting immunotyrosine-based signaling motifs augment zebrafish leukocyte immune-type receptor-mediated phagocytic activity.
    Niemand RR; Stafford JL
    Dev Comp Immunol; 2024 Apr; 153():105121. PubMed ID: 38135021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Probing the Immunoreceptor Tyrosine-Based Inhibition Motif Interaction Protein Partners with Proteomics.
    Gao Y; Xing S; Hu L
    Molecules; 2024 Apr; 29(9):. PubMed ID: 38731468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enteropathogenic Escherichia coli Tir recruits cellular SHP-2 through ITIM motifs to suppress host immune response.
    Yan D; Quan H; Wang L; Liu F; Liu H; Chen J; Cao X; Ge B
    Cell Signal; 2013 Sep; 25(9):1887-94. PubMed ID: 23707390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of neutrophil functions through inhibitory receptors: an emerging paradigm in health and disease.
    Favier B
    Immunol Rev; 2016 Sep; 273(1):140-55. PubMed ID: 27558333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth factor receptor-bound protein 2 contributes to (hem)immunoreceptor tyrosine-based activation motif-mediated signaling in platelets.
    Dütting S; Vögtle T; Morowski M; Schiessl S; Schäfer CM; Watson SK; Hughes CE; Ackermann JA; Radtke D; Hermanns HM; Watson SP; Nitschke L; Nieswandt B
    Circ Res; 2014 Jan; 114(3):444-453. PubMed ID: 24265393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enzymatic self-assembly of an immunoreceptor tyrosine-based inhibitory motif (ITIM).
    Yamagata N; Chen X; Zhou J; Li J; Du X; Xu B
    Org Biomol Chem; 2017 Jul; 15(27):5689-5692. PubMed ID: 28675212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future.
    Daëron M; Jaeger S; Du Pasquier L; Vivier E
    Immunol Rev; 2008 Aug; 224():11-43. PubMed ID: 18759918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitory leukocyte immunoglobulin-like receptors: Immune checkpoint proteins and tumor sustaining factors.
    Kang X; Kim J; Deng M; John S; Chen H; Wu G; Phan H; Zhang CC
    Cell Cycle; 2016; 15(1):25-40. PubMed ID: 26636629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory ITAMs as novel regulators of immunity.
    Blank U; Launay P; Benhamou M; Monteiro RC
    Immunol Rev; 2009 Nov; 232(1):59-71. PubMed ID: 19909356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cell immunoglobulin and immunoreceptor tyrosine-based inhibitory motif domain as a promising immune checkpoint target for the treatment of SLE.
    Zhao J; Li L; Feng X; Fan X; Yin H; Lu Q
    Lupus; 2024 Mar; 33(3):209-216. PubMed ID: 38291414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KIR2DL4 (CD158d), an NK cell-activating receptor with inhibitory potential.
    Faure M; Long EO
    J Immunol; 2002 Jun; 168(12):6208-14. PubMed ID: 12055234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Testing the role of the FcγRIIB immunoreceptor tyrosine-based inhibitory motif in regulation of the B cell immune response.
    Vuyyuru R; Shen S; Manser T
    Immun Inflamm Dis; 2015 Sep; 3(3):247-64. PubMed ID: 26417440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential roles of N- and C-terminal immunoreceptor tyrosine-based inhibition motifs during inhibition of cell activation by killer cell inhibitory receptors.
    Bruhns P; Marchetti P; Fridman WH; Vivier E; Daëron M
    J Immunol; 1999 Mar; 162(6):3168-75. PubMed ID: 10092767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.